Biggest changeCash Flow Years ended December 31, 2022 2021 2020 (in millions) Continuing Operations Net cash provided by (used in) Operating activities $ 180.4 $ 137.3 $ 140.1 Investing activities (63.0) 875.7 571.8 Financing activities (148.1) (963.1) (720.2) Discontinued Operations Net cash provided by (used in) Operating activities 6.3 (7.4) 83.5 Investing activities — (40.0) (20.3) Financing activities — (1.1) (2.6) Effect of exchange rate changes on cash, cash equivalents and restricted cash (5.5) 2.3 11.1 Net change in cash, cash equivalents and restricted cash (29.9) 3.7 63.4 Cash, cash equivalents and restricted cash at beginning of period 140.9 137.2 73.9 Cash, cash equivalents and restricted cash at end of period $ 111.0 $ 140.9 $ 137.3 Years ended December 31, 2022 2021 2020 (in millions) Continuing Operations Net income $ 69.8 $ 1.8 $ 54.3 Non-cash and non-operating activities (1) 114.3 156.6 74.6 Changes in working capital (2.2) (18.1) 14.5 Other operating activities (1.5) (3.0) (3.3) Net cash provided by operating activities, continuing operations $ 180.4 $ 137.3 $ 140.1 (1) Includes depreciation, amortization, amortization of deferred financing costs and original issue discount, debt extinguishment costs, foreign currency exchange gains and losses, pension and postretirement healthcare benefit expense and funding, deferred income tax benefit and provision, net losses on asset disposals, stock compensation, equity in net income and dividends received from affiliated companies. 61 Years ended December 31, 2022 2021 2020 (in millions) Continuing Operations Working capital changes that provided (used) cash: Receivables $ 5.4 $ (33.5) $ 7.0 Inventories 9.9 0.6 (3.0) Prepaids and other current assets — (7.8) (1.4) Accounts payable (10.1) 10.0 6.9 Accrued liabilities (7.4) 12.6 5.0 $ (2.2) $ (18.1) $ 14.5 Years ended December 31, 2022 2021 2020 (in millions) Continuing Operations Purchases of property, plant and equipment $ (58.9) $ (60.0) $ (54.8) Proceeds from business divestitures, net of cash — 978.4 624.3 Payments for business divestiture (3.7) — — Proceeds from sale of assets — — 2.4 Business combinations, net of cash acquired (0.5) (42.6) — Other, net 0.1 (0.1) (0.1) Net cash (used in) provided by investing activities, continuing operations $ (63.0) $ 875.7 $ 571.8 Years ended December 31, 2022 2021 2020 (in millions) Continuing Operations Net cash repayments on debt obligations (9.0) (542.9) (470.3) Dividends paid to stockholders — (435.6) (243.7) Other financing activities (139.1) 15.4 (6.2) Net cash used in financing activities, continuing operations $ (148.1) $ (963.1) $ (720.2) 62 The following discussions related to our cash flows are presented on a continuing operations basis, which excludes the cash flows from our former Performance Chemicals and Performance Materials businesses, which are accounted for as discontinued operations.
Biggest changeFinance obligation due withing the next twelve months is $3.2 million. 53 Cash Flow Years ended December 31, 2023 2022 2021 (in millions) Continuing Operations Net cash provided by (used in) Operating activities $ 137.6 $ 180.4 $ 137.3 Investing activities (65.3) (63.0) 875.7 Financing activities (93.5) (148.1) (963.1) Discontinued Operations Net cash provided by (used in) Operating activities — 6.3 (7.4) Investing activities — — (40.0) Financing activities — — (1.1) Effect of exchange rate changes on cash and cash equivalents (1.3) (5.5) 2.3 Net change in cash and cash equivalents (22.5) (29.9) 3.7 Cash and cash equivalents at beginning of period 110.9 140.9 137.2 Cash and cash equivalents at end of period $ 88.4 $ 111.0 $ 140.9 Years ended December 31, 2023 2022 2021 (in millions) Continuing Operations Net income $ 71.2 $ 69.8 $ 1.8 Non-cash and non-working capital related activities (1) 86.6 114.3 156.6 Changes in working capital (20.8) (2.2) (18.1) Other operating activities 0.6 (1.5) (3.0) Net cash provided by operating activities, continuing operations $ 137.6 $ 180.4 $ 137.3 (1) Includes depreciation, amortization, amortization of deferred financing costs and original issue discount, debt extinguishment costs, foreign currency exchange (gain) loss, pension and postretirement healthcare (benefit) expense, deferred income tax provision (benefit), net (gain) loss on asset disposals, stock compensation expense, equity in net income and dividends received from affiliated companies. 54 Years ended December 31, 2023 2022 2021 (in millions) Continuing Operations Working capital changes that provided (used) cash: Receivables $ (6.1) $ 5.4 $ (33.5) Inventories (1.4) 9.9 0.6 Prepaids and other current assets (1.1) — (7.8) Accounts payable 2.4 (10.1) 10.0 Accrued liabilities (14.6) (7.4) 12.6 $ (20.8) $ (2.2) $ (18.1) Years ended December 31, 2023 2022 2021 (in millions) Continuing Operations Purchases of property, plant and equipment $ (65.3) $ (58.9) $ (60.0) Proceeds from business divestitures, net of cash — — 978.4 Payments for business divestiture, net of cash — (3.7) — Business combinations, net of cash acquired — (0.5) (42.6) Other, net — 0.1 (0.1) Net cash (used in) provided by investing activities, continuing operations $ (65.3) $ (63.0) $ 875.7 Years ended December 31, 2023 2022 2021 (in millions) Continuing Operations Cash repayments on debt obligations $ (9.0) $ (9.0) $ (542.9) Dividends paid to stockholders — — (435.6) Repurchases of common shares (78.7) (136.7) — Tax withholdings on equity award vesting (3.4) (0.3) — Repayment of financing obligation (2.8) (2.7) — Other financing activities 0.4 0.6 15.4 Net cash used in financing activities, continuing operations $ (93.5) $ (148.1) $ (963.1) The following discussions related to our cash flows are presented on a continuing operations basis, which excludes the cash flows from our former Performance Chemicals and Performance Materials businesses, which are accounted for as discontinued operations. 55 Year Ended December 31, 2023 Compared to the Year Ended December 31, 2022 Net cash provided by operating activities was $137.6 million for the year ended December 31, 2023, compared with $180.4 million provided for the year ended December 31, 2022.
However, Adjusted EBITDA reflects our share of the earnings of the Zeolyst Joint Venture that have been recorded as equity in net income from affiliated companies in our consolidated statements of income and includes Zeolyst Joint Venture adjustments on a proportionate basis based on our 50% ownership interest.
However, net income and Adjusted EBITDA reflects our share of the earnings of the Zeolyst Joint Venture that have been recorded as equity in net income from affiliated companies in our consolidated statements of income and includes Zeolyst Joint Venture adjustments on a proportionate basis based on our 50% ownership interest.
Before any impact of hedges, a one percent change in assumed interest rates for our variable interest credit facilities would have an annual impact of approximately $8.9 million on interest expense. The principal balance due in the next twelve months is $9.0 million.
Before any impact of hedges, a one percent change in assumed interest rates for our variable interest credit facilities would have an annual impact of approximately $8.8 million on interest expense. The principal balance due in the next twelve months is $9.0 million.
While natural gas is not a direct feedstock for any product, natural gas powered machinery and equipment are used to heat raw materials and create the chemical reactions necessary to produce end-products. We maintain multiple suppliers wherever possible and structure our customer contracts when possible to allow for the pass-through of raw material and natural gas costs.
While natural gas is not a direct feedstock for any product, natural gas powered machinery and equipment are used to heat raw materials and create the chemical reactions necessary to produce end-products. We maintain multiple suppliers wherever possible and structure our customer contracts when possible to allow for the pass-through of raw material, labor and natural gas costs.
The actual interest payments may differ materially based on actual amounts of long-term debt outstanding and actual interest rates in future periods, as well as the hedging impact from our interest rate cap agreements. 60 Subject to approval by our board of directors, we may raise additional capital or borrowings from time to time or seek to refinance our existing debt.
The actual interest payments may differ materially based on actual amounts of long-term debt outstanding and actual interest rates in future periods, as well as the hedging impact from our interest rate cap agreements. Subject to approval by our board of directors, we may raise additional capital or borrowings from time to time or seek to refinance our existing debt.
The difference between the U.S. federal statutory income tax rate and our effective income tax rate for the year ended December 31, 2022 was mainly due to the impact of the Section 162(m) deduction limitation for “covered” employees with compensation in excess of $1 million, along with the tax deductibility of stock compensation.
The difference between the U.S. federal statutory income tax rate and our effective income tax rate for the year ended December 31, 2022 was mainly due the impact of the Section 162(m) deduction limitation for “covered” employees with compensation in excess of $1 million, along with the tax deductibility of stock compensation.
We determined the fair value of the equity affiliate investment and the fair value step-up was then attributed to the underlying assets of the Zeolyst Joint Venture. Amortization is primarily related to the fair value adjustments associated with fixed assets and intangible assets, including customer relationships and technical know-how.
We determined the fair value of the equity affiliate investment and the fair value step-up was then attributed to the underlying assets of the Zeolyst Joint Venture. Amortization is primarily related to the fair value adjustments associated with intangible assets, including customer relationships and technical know-how.
Adjusted net income is presented as a key performance indicator as we believe it will enhance a prospective investor’s understanding of our results of operations and financial condition. Adjusted net income may not be comparable with net income or adjusted net income as defined by other companies.
Adjusted net income is presented as a key performance indicator as we believe it will enhance a prospective investor’s understanding of our results of operations and financial 51 condition. Adjusted net income may not be comparable with net income or adjusted net income as defined by other companies.
Subsequent reversal of an impairment loss is not permitted. For the purposes of the quantitative goodwill impairment test, we determine the fair value of our reporting units using a combination of a market approach and an income, or discounted cash flow, approach.
Subsequent reversal of an impairment loss is not permitted. 59 For the purposes of the quantitative goodwill impairment test, we determine the fair value of our reporting units using a combination of a market approach and an income, or discounted cash flow, approach.
Although achievement of the performance condition is subject to continued service with us, the terms of awards issued 69 with performance conditions stipulate that the performance vesting condition can be attained for a period of six months following separation from service under certain circumstances, depending on the means of separation from the Company and subject to other factors such as individual separation agreements.
Although achievement of the performance condition is subject to continued service with us, the terms of awards issued with performance conditions stipulate that the performance vesting 61 condition can be attained for a period of six months following separation from service under certain circumstances, depending on the means of separation from the Company and subject to other factors such as individual separation agreements.
These demand fluctuations results in higher sales and working capital requirements in the second and third quarter. 45 Foreign Currency As a global business, we are subject to the impact of gains and losses on currency translations, which occur when the financial stat ements of foreign operations are translated into U.S. dollars.
These demand fluctuations results in higher sales and working capital requirements in the second and third quarters. 45 Foreign Currency As a global business, we are subject to the impact of gains and losses on currency translations, which occur when the financial stat ements of foreign operations are translated into U.S. dollars.
Each limits the ability of the Borrower and its restricted subsidiaries to incur certain indebtedness or liens, merge, consolidate or liquidate, dispose of certain property, make investments or declare or pay dividends, make optional payments, modify certain debt instruments, enter into certain transactions with affiliates, enter into certain sales and leasebacks, and certain other non-financial restrictive covenants.
Each limits the ability of the Company and its restricted subsidiaries to incur certain indebtedness or liens, merge, consolidate or liquidate, dispose of certain property, make investments or declare or pay dividends, make optional payments, modify certain debt instruments, enter into certain transactions with affiliates, enter into certain sales and leasebacks, and certain other non-financial restrictive covenants.
Most of our Ecoservices contracts feature take-or-pay volume protection and/or quarterly price adjustments for commodity inputs, labor, the Chemical Engineering Index (U.S. chemical plant construction cost index) and natural gas. Over 80% of our Ecoservices segment sales for the year ended December 31, 2022 were under contracts featuring quarterly price adjustments.
Most of our Ecoservices contracts feature take-or-pay volume protection and/or quarterly price adjustments for commodity inputs, labor, the Chemical Engineering Index (U.S. chemical plant construction cost index) and natural gas. Over 80% of our Ecoservices segment sales for the year ended December 31, 2023 were under contracts featuring quarterly price adjustments.
(b) Represents the amortization of the fair value adjustments associated with the equity affiliate investment in the Zeolyst Joint Venture as a result of the combination of the businesses of PQ Holdings Inc. and Eco Services Operations LLC in May 2016 (the “Business Combination”).
(b) Represents the amortization of the fair value adjustments associated with the equity affiliate investment in the Zeolyst Joint Venture as a result of the combination of the businesses of PQ Holdings Inc. and Eco Services Operations LLC in May 2016.
Effective on August 1, 2021, we completed the sale of our Performance Chemicals business to Sparta Aggregator L.P., a partnership with Koch Minerals & Trading, LLC and Cerberus Capital Management, L.P. for $1.1 billion.
Effective on August 1, 2021, we completed the sale of our Performance Chemicals business to Sparta Aggregator L.P., a partnership with Koch Minerals & Trading, LLC and Cerberus Capital Management, L.P.
Demand for the Zeolyst Joint Venture products fluctuates based upon the timing of our customer’s fixed bed catalyst replacements. We share proportionally in the management of our joint ventures with the other parties to each such joint venture.
Demand for the Zeolyst Joint Venture products fluctuates based upon the timing of our customer’s fixed bed catalyst replacements. We share proportionally in the management of our joint venture with the other parties to such joint venture.
For the annual 67 assessments in 2022 and 2021, we bypassed the option to perform the qualitative assessment and proceeded directly to performing the quantitative goodwill impairment test for each of our reporting units. The quantitative test identifies both the potential existence of impairment and the amount of impairment loss.
For the annual assessments in 2023 and 2022, we bypassed the option to perform the qualitative assessment and proceeded directly to performing the quantitative goodwill impairment test for each of our reporting units. The quantitative test identifies both the potential existence of impairment and the amount of impairment loss.
We believe that our existing cash, cash equivalents and cash flows from operations, combined with availability under our ABL Facility, will be sufficient to meet our presently anticipated future cash needs for at least the next 12 months. We may also pursue strategic acquisition opportunities, which may impact our future cash requirements.
We believe that our existing cash, cash equivalents and cash flows from operations, combined with availability under our ABL Facility, will be sufficient to meet our presently anticipated future cash needs for at least the next twelve months. We may also pursue strategic acquisition or divestiture opportunities, which may impact our future cash requirements.
Adjusted net income consists of net income (loss) attributable to Ecovyst Inc. adjusted for (i) non-operating income or expense and (ii) the impact of certain non-cash, nonrecurring or other items included in net income (loss) that we do not consider indicative of our ongoing operating performance.
Adjusted net income consists of net income (loss) adjusted for (i) non-operating income or expense and (ii) the impact of certain non-cash, nonrecurring or other items included in net income (loss) that we do not consider indicative of our ongoing operating performance.
The results of operations, financial condition, and cash flows for the Performance Materials and Performance Chemicals businesses are presented herein as discontinued operations. Refer to Note 4 and Note 5 of our Consolidated Financial Statements for additional information.
The results of operations, financial condition, and cash flows for the Performance Materials and Performance Chemicals businesses are presented herein as discontinued operations for the 2022 and 2021 periods presented. Refer to Note 4 of our consolidated financial statements for additional information.
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. Overview We are a leading integrated and innovative global provider of specialty catalysts and services. We believe that our products, which are predominantly inorganic, and services contribute to improving the sustainability of the environment.
ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. Overview We are a leading integrated and innovative global provider of advanced materials, specialty catalysts and services. We believe that our products and services contribute to improving the sustainability of the environment.
We may seek, subject to market conditions and other factors, opportunities to repurchase, refinance or otherwise reprice our debt. ABL Facility On May 4, 2016, we entered a $200.0 million senior secured ABL facility, which provided for $200.0 million in revolving credit commitment (the “ABL Facility”).
We may seek, subject to market conditions and other factors, opportunities to repurchase, refinance or otherwise reprice our debt. 56 ABL Facility On May 4, 2016, we entered a $200.0 million senior secured ABL facility, which provided for $200.0 million in revolving credit commitments.
Our capital expenditures include both maintenance of business, which includes spending on maintenance and health, safety and environmental initiatives as well as growth, which includes spending to drive organic sales growth and cost savings initiatives.
Our capital expenditures include both maintenance of business, which include spending on maintenance and HSE initiatives as well as growth, which includes spending to drive organic sales growth and cost savings initiatives.
Interest payments due within the next twelve months are $59.5 million using the interest rate effective as of December 31, 2022 on our variable interest credit facilities. Interest on long-term debt excludes amortization of deferred financing fees and original issue discount.
Interest payments due within the next twelve months are $70.7 million using the interest rate effective as of December 31, 2023 on our variable interest credit facilities. Interest on long-term debt excludes amortization of deferred financing fees and original issue discount.
Years ended December 31, 2022 2021 2020 (in millions) Maintenance capital expenditures $ 46.9 $ 42.8 $ 36.0 Growth capital expenditures 9.0 19.6 10.2 Total capital expenditures $ 55.9 $ 62.4 $ 46.2 Capital expenditures remained at a level sufficient for required maintenance and certain expansion growth initiatives during these periods.
Years ended December 31, 2023 2022 2021 (in millions) Maintenance capital expenditures $ 54.1 $ 46.9 $ 42.8 Growth capital expenditures 8.1 9.0 19.6 Total capital expenditures $ 62.2 $ 55.9 $ 62.4 57 Capital expenditures remained at a level sufficient for required maintenance and certain expansion growth initiatives during these periods.
Over the course of the next twelve months and beyond, we anticipate making significant cash payments for known contractual and other obligations, including: Principal and interest on long-term debt As of December 31, 2022, our total indebtedness was $886.5 million, with up to $59.7 million of available borrowings under our ABL.
Over the course of the next twelve months and beyond, we anticipate making significant cash payments for known contractual and other obligations, including: Principal and interest on long-term debt As of December 31, 2023, our total indebtedness was $877.5 million, with up to $63.8 million of available borrowings under our ABL.
Our liquidity requirements are significant, primarily due to debt service requirements. As reported, our cash interest expense for the years ended December 31, 2022, 2021 and 2020 was approximately $35.4 million, $59.0 million and $90.3 million, respectively.
Our liquidity requirements are significant, primarily due to debt service requirements. As reported, our cash interest expense for the years ended December 31, 2023, 2022 and 2021 was approximately $42.1 million, $35.4 million and $59.0 million, respectively.
In 2022, we served global customers across many end uses and, as of December 31, 2022, operated out of ten strategically located manufacturing facilities. On December 14, 2020, we completed the sale of our Performance Materials business to Potters Buyer, LLC, an affiliate of The Jordan Company, L.P., for a purchase price of $650 million.
In 2023, we served global customers across many end uses and, as of December 31, 2023, operated out of ten strategically located manufacturing facilities. On December 14, 2020, we completed the sale of our Performance Materials business to Potters Buyer, LLC, an affiliate of The Jordan Company, L.P.
(2) The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalyst Technologies segment is $50.3 million for the year ended December 31, 2022, which includes $27.9 million of equity in net income, excluding $6.4 million of amortization of investment in affiliate step-up, plus $16.0 million of joint venture depreciation, amortization and interest.
The Adjusted EBITDA from the Zeolyst Joint Venture included in the Advanced Materials & Catalysts segment was $50.3 million for the year ended December 31, 2022, which includes $27.9 million of equity in net income, excluding $6.4 million of amortization of investment in affiliate step-up plus $16.0 million of joint venture depreciation, amortization and interest.
Because our Catalyst Technologies segment includes our 50% interest in the Zeolyst Joint Venture, we include an adjustment for our 50% proportionate share of depreciation, amortization and interest expense of the Zeolyst Joint Venture.
Because our Advanced Materials & Catalysts segment includes our 50% interest in the Zeolyst Joint Venture, we include an adjustment for our 50% proportionate share of depreciation, amortization and interest expense of the Zeolyst Joint Venture.
The second ratio compares the ABL Facility availability of the U.S. revolving credit facility against a $15.0 million threshold. As of December 31, 2022, we were in compliance with all covenants under our debt agreements. The 2021 Term Loan Facility and the ABL Facility contain various non-financial restrictive covenants.
The second ratio compares the ABL Facility availability of the U.S. revolving credit facility against a $15.0 million threshold. As of December 31, 2023, we were in compliance with the financial covenant under the ABL Facility. The 2021 Term Loan Facility and the ABL Facility contain various restrictive covenants.
Strategic decisions involving a particular group of assets may trigger an assessment of the recoverability of the related assets. Such an assessment could result in impairment losses. 68 For further information see Note 16 Goodwill and Other Intangible Assets. Income Taxes We operate within multiple taxing jurisdictions and are subject to tax filing requirements and potential audits within these jurisdictions.
Strategic decisions involving a particular group of assets may trigger an assessment of the recoverability of the related assets. Such an assessment could result in impairment losses. For further information, see Note 14 to these consolidated financial statements. 60 Income Taxes We operate within multiple taxing jurisdictions and are subject to tax filing requirements and potential audits within these jurisdictions.
Adjusted Net Income Summarized adjusted net income information is shown below in the following table: Years ended December 31, 2022 2021 Pre-tax Tax expense (benefit) After-tax Pre-tax Tax expense (benefit) After-tax (in millions) Reconciliation of net income attributable to Ecovyst Inc. to Adjusted Net Income (1)(2) Net income from continuing operations $ 94.7 $ 24.9 $ 69.8 $ 13.9 $ 12.1 $ 1.8 Amortization of investment in affiliate step-up (b) 6.4 1.5 4.9 6.5 1.6 4.9 Debt extinguishment costs — — — 26.9 6.6 20.3 Net loss on asset disposals (c) 3.6 0.9 2.7 5.7 1.4 4.3 Foreign currency exchange loss (d) 1.4 0.4 1.0 4.7 1.0 3.7 LIFO benefit (e) (0.2) (0.1) (0.1) (1.9) (0.5) (1.4) Transaction and other related costs (f) 7.0 1.1 5.9 2.0 0.5 1.5 Equity-based compensation 20.6 (0.1) 20.7 31.8 7.7 24.1 Restructuring, integration and business optimization expenses (g) 11.6 2.8 8.8 3.9 0.7 3.2 Other (h) (0.7) (0.2) (0.5) 1.8 0.7 1.1 Adjusted Net Income, including Impact of Discrete Tax Items 144.4 31.2 113.2 95.3 31.8 63.5 Impact of Discrete Tax Items (3) — — — — (6.1) 6.1 Adjusted Net Income $ 144.4 $ 31.2 $ 113.2 $ 95.3 $ 25.7 $ 69.6 (1) We define adjusted net inco me as net income attributable to Ecovyst Inc. adjusted for non-operating income or expense and the impact of certain non-cash or other items that are included in net income that we do not consider indicative of our ongoing operating performance.
Adjusted Net Income Summarized adjusted net income information is shown below in the following table: Years ended December 31, 2023 2022 Pre-tax Tax expense (benefit) After-tax Pre-tax Tax expense (benefit) After-tax (in millions) Reconciliation of net income to Adjusted Net Income (1)(2) Net income from continuing operations $ 82.0 $ 10.8 $ 71.2 $ 94.7 $ 24.9 $ 69.8 Amortization of investment in affiliate step-up (b) 6.4 1.6 4.8 6.4 1.5 4.9 Net loss on asset disposals (c) 4.1 1.0 3.1 3.6 0.9 2.7 Foreign currency exchange (gain) loss (d) (1.3) (0.3) (1.0) 1.4 0.4 1.0 LIFO expense (benefit) (e) 3.5 0.9 2.6 (0.2) (0.1) (0.1) Transaction and other related costs (f) 3.0 0.8 2.2 7.0 1.1 5.9 Equity-based compensation 16.0 1.5 14.5 20.6 (0.1) 20.7 Restructuring, integration and business optimization expenses (g) 2.7 0.7 2.0 11.6 2.8 8.8 Other (h) 0.8 0.2 0.6 (0.7) (0.2) (0.5) Adjusted Net Income, including Impact valuation allowance release 117.2 17.2 100.0 144.4 31.2 113.2 Impact of valuation allowance release (3) — 10.2 (10.2) — — — Adjusted Net Income $ 117.2 $ 27.4 $ 89.8 $ 144.4 $ 31.2 $ 113.2 (1) We define adjusted net inco me as net income attributable to Ecovyst Inc. adjusted for non-operating income or expense and the impact of certain non-cash or other items that are included in net income that we do not consider indicative of our ongoing operating performance.
We conduct operations through two repor ting segments: (1) Ecoservices and (2) Catalyst Technologies (including our 50% interest in the Zeolyst Joint Venture).
We conduct operations through two repor ting segments: (1) Ecoservices and (2) Advanced Materials & Catalysts (including our 50% interest in the Zeolyst Joint Venture).
(e) Represents non-cash adjustments to the Company’s LIFO reserves for certain inventories in the U.S. that are valued using the LIFO method, which we believe provides a means of comparison to other companies that may not use the same basis of accounting for inventories.
(e) Represents non-cash adjustments to the Company’s LIFO reserves for certain inventories in the U.S. that are valued using the LIFO method, effectively reflecting the results as if these inventories were valued using the FIFO 50 method, which we believe provides a means of comparison to other companies that may not use the same basis of accounting for inventories.
Growth capital expenditures include spending to drive organic sales growth and cost savings initiatives. These capital expenditures represent our “book” capital expenditures for which the company has recorded, but not necessarily paid for the capital expenditures.
Capital Expenditures Maintenance capital expenditures include spending on maintenance of business, health, safety and environmental initiatives. Growth capital expenditures include spending to drive organic sales growth and cost savings initiatives. These capital expenditures represent our “book” capital expenditures for which the company has recorded, but not necessarily paid for the capital expenditures.
When a customer procures goods under this method, we consider the combination of the pricing quote and the purchase order to create enforceable rights and obligations. Absent either a MSA or pricing quote, we consider an individual purchase order to create enforceable rights and obligations.
When a customer procures goods under this method, we consider the combination of the pricing quote and the purchase order to create enforceable rights and obligations.
Net cash used in investing activities was $63.0 million for the year ended December 31, 2022, compared to net cash provided of $875.7 million during the year ended December 31, 2021. Cash used in investing activities consisted of $58.9 million and $60.0 million to fund capital expenditures during the years ended December 31, 2022 and 2021, respectively.
Net cash used in investing activities was $65.3 million for the year ended December 31, 2023, compared to net cash used of $63.0 million during the year ended December 31, 2022. Cash used in investing activities consisted of $65.3 million and $58.9 million to fund capital expenditures during the years ended December 31, 2023 and 2022, respectively.
Restricted stock awards and stock options issued with performance conditions vest based on the occurrence of a defined liquidity event upon which certain investment funds affiliated with CCMP receive proceeds exceeding certain thresholds.
Prior to the Company’s IPO, the Company issued restricted stock awards and stock options with performance conditions that were based on the occurrence of a defined liquidity event upon which certain investment funds affiliated with CCMP receive proceeds exceeding defined thresholds.
Interest Expense, Net Interest expense, net for the year ended December 31, 2022 was $37.2 million, an increase of $0.2 million, as compared with $37.0 million for the year ended December 31, 2021.
Interest Expense, Net Interest expense, net for the year ended December 31, 2023 was $44.7 million, an increase of $7.5 million, as compared with $37.2 million for the year ended December 31, 2022.
This was only partially offset by increased volume and higher average selling prices. 50 A reconciliation of net income attributable to Ecovyst Inc. to Adjusted EBITDA is as follows: Years ended December 31, 2022 2021 (in millions) Reconciliation of net income attributable to Ecovyst Inc. to Adjusted EBITDA Net income from continuing operations $ 69.8 $ 1.8 Provision for income taxes 24.9 12.1 Interest expense, net 37.2 37.0 Depreciation and amortization 79.2 79.7 EBITDA 211.1 130.6 Joint venture depreciation, amortization and interest (a) 16.0 15.6 Amortization of investment in affiliate step-up (b) 6.4 6.5 Debt extinguishment costs — 26.9 Net loss on asset disposals (c) 3.6 5.7 Foreign currency exchange loss (d) 1.4 4.7 LIFO benefit (e) (0.2) (1.9) Transaction and other related costs (f) 7.0 2.0 Equity-based compensation 20.6 31.8 Restructuring, integration and business optimization expenses (g) 11.6 3.9 Other (h) (0.7) 1.8 Adjusted EBITDA $ 276.8 $ 227.6 (a) We use Adjusted EBITDA as a performance measure to evaluate our financial results.
A reconciliation of net income attributable to Ecovyst Inc. to Adjusted EBITDA is as follows: Years ended December 31, 2023 2022 (in millions) Reconciliation of net income to Adjusted EBITDA Net income from continuing operations $ 71.2 $ 69.8 Provision for income taxes 10.8 24.9 Interest expense, net 44.7 37.2 Depreciation and amortization 84.6 79.2 EBITDA 211.3 211.1 Joint venture depreciation, amortization and interest (a) 13.4 16.0 Amortization of investment in affiliate step-up (b) 6.4 6.4 Net loss on asset disposals (c) 4.1 3.6 Foreign currency exchange (gain) loss (d) (1.3) 1.4 LIFO expense (benefit) (e) 3.5 (0.2) Transaction and other related costs (f) 3.0 7.0 Equity-based compensation 16.0 20.6 Restructuring, integration and business optimization expenses (g) 2.7 11.6 Other (h) 0.8 (0.7) Adjusted EBITDA $ 259.9 $ 276.8 (a) We use Adjusted EBITDA as a performance measure to evaluate our financial results.
Additionally, in connection with secondary offerings of the Company’s common stock in August and November 2022, the Company repurchased 6,500,000 and 8,000,000 shares of its common stock sold in the offerings, respectively, from the underwriters at a price of $8.36 per share and $7.88 per share, respectively, simultaneous with the closing of the respective offerings, for a total of $117.3 million.
Additionally, in connection with secondary offerings of the Company’s common stock in August and November 2022, the Company repurchased 14,500,000 shares of its common stock sold in the offerings from the underwriters at a weighted average price of $8.09 per share concurrently with the closing of the offerings, for a total of $117.3 million.
(f) Relates to certain transaction costs, including debt financing, due diligence and other costs related to transactions that are completed, pending or abandoned, that we believe are not representative of our ongoing business operations.
(f) Relates to certain transaction costs, including debt financing, due diligence and other costs related to transactions that are completed, pending or abandoned, that we believe are not representative of our ongoing business operations. (g) Includes the impact of restructuring, integration and business optimization expenses, which are incremental costs that are not representative of our ongoing business operations.
Currently there is no history in which customers fail to meet the contractual minimum. Revenue from product sales are recorded at the sales price, which includes estimates of variable consideration for which reserves are established and which result from discounts, returns or other allowances that are offered within contracts with our customers.
Revenue from product sales are recorded at the sales price, which includes estimates of variable consideration for which reserves are established and which result from discounts, returns or other allowances that are offered within contracts with our customers.
Approximately 6% of our sales for the years ended December 31, 2022 and 2021 in currencies other than the U.S. dollar.
We operate in various geographies with approximately 6% of our sales for the years ended December 31, 2023 and 2022 in currencies other than the U.S. dollar.
Joint Ventures We account for our investments in our equity joint ventures under the equity method. Our joint venture, the Zeolyst Joint Venture, manufactures high performance, specialty, zeolite-based catalysts for use in the polymers and engineered plastics, emission control, refining and petrochemical industries and other areas of the broader chemicals industry.
Joint Ventures We account for our investments in our equity joint ventures under the equity method. Our joint venture, the Zeolyst Joint Venture, manufactures high performance, specialty, zeolite-based catalysts, used in emission control, refining and petrochemical industry applications and by the broader chemicals industry.
Ecoservices: We are a leading provider of sulfuric acid recycling services to North American refineries for the production of alkylate, an essential gasoline component for lowering vapor pressure and increasing octane to meet stringent gasoline specifications and fuel efficiency standards. We are also a leading North American producer of on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications.
Ecoservices: We are a leading provider of sulfuric acid recycling to the North American refining industry for the production of alkylate, an essential gasoline component for lowering vapor pressure and increasing octane to meet stringent gasoline specifications and fuel efficiency standards.
We also did not make any purchases from suppliers in Russia or Ukraine. As Russia’s invasion of Ukraine continues to unfold, we will continue to monitor compliance with sanctions imposed by the U.S. government and other countries. Recent Developments Late in the fourth quarter of 2022, our Ecoservices business was adversely affected by Winter Storm Elliott.
We also did not make any purchases from suppliers in Russia or Ukraine. As Russia’s invasion of Ukraine continues to unfold, we will continue to monitor compliance with sanctions imposed by the U.S. government and other countries. We continue to monitor the developments in the Middle East.
The Adjusted EBITDA from the Zeolyst Joint Venture included in the Catalyst Technologies segment is $42.5 million for the year ended December 31, 2020, which includes $21.2 million of equity in net income, excluding $6.6 million of amortization of investment in affiliate step-up, plus $14.7 million of joint venture depreciation, amortization and interest.
(2) The Adjusted EBITDA from the Zeolyst Joint Venture included in the Advanced Materials & Catalysts segment was $50.5 million for the year ended December 31, 2023, which includes $30.7 million of equity in net income, excluding $6.4 million of amortization of investment in affiliate step-up plus $13.4 million of joint venture depreciation, amortization and interest.
We identify a contract when an agreement with a customer creates legally enforceable rights and obligations, which occurs when a contract has been approved by both parties, the parties are committed to perform their respective obligations, each party’s rights and payment terms are clearly identified, commercial substance exists and it is probable that we will collect the consideration to which we are entitled. 66 Evidence of a contract with a customer may take the form of a master service agreement (“MSA”), a MSA in combination with an underlying purchase order, a combination of a pricing quote with an underlying purchase order or an individual purchase order received from a customer.
We identify a contract when an agreement with a customer creates legally enforceable rights and obligations, which occurs when a contract has been approved by both parties, the parties are committed to perform their respective obligations, each party’s rights and payment terms are clearly identified, commercial substance exists and it is probable that we will collect the consideration to which we are entitled.
Selling, General and Administrative Expenses Selling, general and administrative expenses for the year ended December 31, 2022 were $85.3 million, a decrease of $12.5 million compared with $97.8 million for the year ended December 31, 2021.
Selling, General and Administrative Expenses Selling, general and administrative expenses for the year ended December 31, 2023 were $79.2 million, a decrease of $6.1 million compared with $85.3 million for the year ended December 31, 2022.
Results of Operations Year Ended December 31, 2022 Compared to the Year Ended December 31, 2021 Highlights The following is a summary of our financial performance for the year ended December 31, 2022 compared with the year ended December 31, 2021. Sales Sales increased $209.0 million to $820.2 million.
Results of Operations Year Ended December 31, 2023 Compared to the Year Ended December 31, 2022 Highlights The following is a summary of our financial performance for the year ended December 31, 2023 compared with the year ended December 31, 2022. Sales Sales decreased $129.1 million to $691.1 million.
We had no sales to customers in Ukraine and our sales to a customer in Russia were immaterial for the year ended December 31, 2022 and have been discontinued. Sales to this customer in Russia represented 2% of total sales for the years ended December 31, 2021 and 2020, respectively.
We have no operations in Russia or Ukraine. We had no sales to customers in Ukraine and Russia in December 31, 2023 and our sales to a customer in Russia were immaterial for the year ended December 31, 2022 and 2% for the year ended December 31, 2021.
Our net debt was $775.6 million, including cash of $110.9 million. Our total available liquidity as of December 31, 2022 was $170.6 million, which represents our cash on hand of $110.9 million plus our excess availability under our ABL of $59.7 million, after giving effect to $4.0 million of outstanding letters of credit and no revolving credit facility borrowings.
Our total available liquidity as of December 31, 2023 was $152.2 million, which represents our cash on hand of $88.4 million plus our excess availability under our ABL of $63.8 million, after giving effect to $4.0 million of outstanding letters of credit and no revolving credit facility borrowings.
This segment includes our 50% interest in the Zeolyst Joint Venture, where we are a leading global supplier of zeolites used for catalysts that help produce renewable fuels, remove nitrogen oxides from diesel engine emissions as well as sulf ur from fuels during the refining process.
This segment includes our 50% interest in the Zeolyst Joint Venture, where we are a leading global supplier of zeolites used for catalysts that support the production of sustainable fuels, remove nitrogen oxides from diesel engine emissions and are broadly applied in refining and petrochemical processes.
Critical Accounting Policies and Estimates We prepare our consolidated financial statements in conformity with GAAP and our significant accounting policies are described in Note 2 to our consolidated financial statements. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts and related disclosures.
The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts and related disclosures.
In addition, there was annual commitment fee equal to 0.375%, with a step-down to 0.25% based on average usage of the revolving credit borrowings available. 64 On June 9, 2021, we amended the ABL Facility to decrease the aggregate amount of revolving loan commitments available to $100.0 million, consisting of $90.0 million in U.S. commitments and $10.0 million in European commitments and extended the maturity date to August 2, 2026.
On June 9, 2021, we amended the ABL Facility a third time to decrease the aggregate amount of revolving loan commitments available to $100.0 million, consisting of $90.0 million in U.S. commitments and $10.0 million in European commitments and extended the maturity date to August 2, 2026.
The increase in sales was primarily due to the contribution from higher sales volume of $7.1 million and higher average selling prices of $4.6 million, partially offset by the unfavorable effects of foreign currency translation of $4.7 million.
The decrease in sales was primarily due to lower sales volume of $24.2 million, partially offset by higher average selling prices of $12.4 million and the effects of foreign currency translation of $0.4 million.
Equity in Net Income of Affiliated Companies Equity in net income of affiliated companies for the year ended December 31, 2021 was $27.7 million, an increase of $6.7 million, compared with income of $21.0 million for the year ended December 31, 2020.
Equity in Net Income from Affiliated Companies Equity in net income from affiliated companies for the year ended December 31, 2023 was $30.6 million, an increase of $2.9 million or 10.5%, compared with $27.7 million for the year ended December 31, 2022.
We have the availability to request letters of credit under the ABL Facility. We had $4.0 million of letters of credit outstanding as of December 31, 2022, which reduce available borrowings under the ABL Facility by such amounts.
Revolving credit borrowings are payable at our option throughout the term of the ABL Facility with the balance due August 2, 2026. We have the availability to request letters of credit under the ABL Facility. We had $4.0 million of letters of credit outstanding as of December 31, 2023, which reduce available borrowings under the ABL Facility by such amounts.
Spent sulfuric acid for our Ecoservices segment is supplied by customers for a nominal charge as part of their contracts. The primary raw materials used in the manufacture of products in our Catalyst Technologies segment include sodium silicate and cesium hydroxide.
The primary raw materials for our Ecoservices segment include spent sulfuric acid, sulfur, acids, bases (including sodium hydroxide, or “caustic soda”), and certain metals. Spent sulfuric acid for our Ecoservices segment is supplied by customers for a nominal charge as part of their contracts.
Certain of our contracts include multiple performance obligations under which the purchase price for each distinct performance obligation is defined in the contract. These distinct performance obligations may include stand-ready provisions, which are arrangements to provide a customer assurance that they will have access to output from our manufacturing facilities, or monthly reservations of capacity fees.
These distinct performance obligations may include stand-ready provisions, which are arrangements to provide a customer assurance that they will have access to output from our manufacturing facilities, or monthly reservations of capacity fees. We consider stand-ready provisions and reservation of capacity fees to be performance obligations satisfied over time.
Our exposure to fluctuations in raw materials prices is limited, as the majority of pass-through contract provisions reset based on fluctuations in the underlying raw material price. MSAs in our Ecoservices segment also contain take-or-pay arrangements, whereby the customer would incur a penalty in the form of a shortfall volume fee.
MSAs in the our Ecoservices segment may contain provisions whereby raw materials costs are passed-through to the customer per the terms of their contract. Our exposure to fluctuations in raw materials prices is limited, as the majority of pass-through contract provisions reset based on fluctuations in the underlying raw material price.
The $32.6 million decrease in cash from working capital as compared to the prior year was primarily due to favorable changes in accrued liabilities, inventories, and accounts payables, which were offset by unfavorable changes in accounts receivable and prepaids.
The decrease in cash from working capital during the year ended December 31, 2023 of $18.6 million was unfavorable compared to the year ended December 31, 2022 primarily due to unfavorable changes in receivables, inventories, prepaids and other current assets and accrued liabilities, which were offset by favorable change in accounts payable.
All of our defined benefit pension plan obligations are under defined benefit pension plans that are frozen. Included in this line-item are rounding discrepancies that may arise from rounding from dollars (in thousands) to dollars (in millions).
Included in this line-item are rounding discrepancies that may arise from rounding from dollars (in thousands) to dollars (in millions).
Following this amendment, U.S. dollar-denominated borrowings under the ABL Facility bear interest at a rate equal to an adjusted SOFR rate or the base rate plus a margin of between 1.25% and 1.75% or 0.25% to 0.75%, respectively. 2021 Term Loan Facility On June 9, 2021, we entered into an agreement for a senior secured term loan facility (the “2021 Term Loan Facility”) for an aggregate principal amount of $900.0 million, with an original issue discount of 0.25% and interest at a floating rate of LIBOR (with a 0.50% minimum LIBOR floor) plus 2.75% per annum, with a maturity date of June 9, 2028.
We were in compliance with all debt covenants as of December 31, 2023 and 2022, respectively. 2021 Term Loan Facility On June 9, 2021, we entered into an agreement for a senior secured term loan facility (the “2021 Term Loan Facility”) in an aggregate principal amount of $900.0 million, with an original issue discount of 0.25% and interest at a floating rate of LIBOR (with a 0.50% minimum LIBOR floor) plus 2.75% per annum (or, depending on the Borrower’s first lien net leverage ratio, 2.50%), with a maturity date of June 9, 2028.
Although the current conflict has created global economic and political uncertainties and affected certain supply chain disruptions, we do not believe we have significant exposure in those countries. We have no operations in Russia or Ukraine.
Economic Effects on our Business and Results We continue to monitor the developments in Russia and Ukraine, as well as the related economic sanctions and export controls imposed on certain industry sectors. Although the current conflict has created global economic and political uncertainties and affected certain supply chain disruptions, we do not believe we have significant exposure in those countries.
Debt December 31, 2022 2021 (in millions) Senior Secured Term Loan Facility due June 2028 (the "2021 Term Loan Facility") $ 886.5 $ 895.5 ABL Facility — — Total debt 886.5 895.5 Original issue discount (7.5) (8.8) Deferred financing costs (4.1) (4.9) Total debt, net of original issue discount and deferred financing costs 874.9 881.8 Less: current portion (9.0) (9.0) Total long-term debt, excluding current portion $ 865.9 $ 872.8 As of December 31, 2022 our total debt was $886.5 million excluding the original issue discount of $7.5 million and deferred financing fees of $4.1 million for our senior secured credit facilities and notes.
Year Ended December 31, 2022 Compared to the Year Ended December 31, 2021 A discussion of our cash flows for the year ended December 31, 2022 compared to the year ended December 31, 2021 is set forth in Part II, Item 7 of our Form 10-K for the year ended December 31, 2022 under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Debt December 31, 2023 2022 (in millions) Senior Secured Term Loan Facility due June 2028 $ 877.5 $ 886.5 ABL Facility — — Total debt 877.5 886.5 Original issue discount (6.2) (7.5) Deferred financing costs (3.4) (4.1) Total debt, net of original issue discount and deferred financing costs 867.9 874.9 Less: current portion (9.0) (9.0) Total long-term debt, excluding current portion $ 858.9 $ 865.9 As of December 31, 2023 our total debt was $877.5 million excluding the original issue discount of $6.2 million and deferred financing fees of $3.4 million for our senior secured credit facilities.
As of December 31, 2022, $313.3 million was available for additional share repurchases under the program. Basis of Presentation Our zeolite catalysts product group operates through the Zeolyst Joint Venture, which we account for as an equity method investment in accordance with accounting principles generally accepted in the United States (“GAAP”).
Basis of Presentation Our zeolite catalysts product group operates through the Zeolyst Joint Venture, which we account for as an equity method investment in accordance with accounting principles generally accepted in the United States (“GAAP”). We do not record sales by the Zeolyst Joint Venture as revenue and such sales are not consolidated within our results of operations.
Ecoservices : Adjusted EBITDA for the year ended December 31, 2022 was $227.8 million, an increase of $50.1 million, or 28.2%, compared to $177.7 million for the year ended December 31, 2021.
Ecoservices : Adjusted EBITDA for the year ended December 31, 2023 was $200.0 million, a decrease of $27.8 million, or 12.2%, compared to $227.8 million for the year ended December 31, 2022.
Provision for Income Taxes The provision for income taxes for the year ended December 31, 2022 was a $24.9 million provision compared to a $12.1 million provision for the year ended December 31, 2021. The effective income tax rate for the year ended December 31, 2022 was 26.3% compared to 87.1% for the year ended December 31, 2021.
The effective income tax rate for the year ended December 31, 2023 was 13.2% compared to 26.3% for the year ended December 31, 2022.
From the announcement date of the program in April 2022 through December 31, 2022, the Company repurchased 1,970,763 shares of its common stock on the open market at an average price of $9.82 per share, for a total of $19.4 million.
As of December 31, 2023, $234.6 million was available for additional share repurchases under the program. During the year-ended December 31, 2022, the Company repurchased 1,970,763 shares on the open market at an average price of $9.82 per share, for a total of $19.4 million, excluding brokerage commissions.
Following this amendment, the 2021 Term Loan Facility bears interest at an adjusted SOFR rate (with a 0.50% minimum floor) plus 2.75% per annum (or, depending on the Borrower’s first lien net leverage ratio, 2.50%). 2020 Term Loan Facility – Repaid in 2021 On July 22, 2020, we entered into an agreement for a senior secured term loan facility (the “2020 Term Loan Facility”) for an aggregate principal amount of $650.0 million.
On February 9, 2023, we amended the 2021 Term Loan Facility to replace LIBOR with SOFR as the benchmark interest rate. Following this amendment, the 2021 Term Loan Facility bears interest at an adjusted SOFR rate (with a 0.50% minimum floor) plus 2.75% per annum (or, depending on the first lien net leverage ratio, 2.50%).
Years ended December 31, Change 2022 2021 $ % (in millions, except percentages) Sales $ 820.2 $ 611.2 $ 209.0 34.2 % Cost of goods sold 595.5 434.5 161.0 37.1 % Gross profit 224.7 176.7 48.0 27.2 % Gross profit margin 27.4 % 28.9 % Selling, general and administrative expenses 85.3 97.8 (12.5) (12.8) % Other operating expense, net 35.0 24.3 10.7 44.0 % Operating income 104.4 54.6 49.8 91.2 % Operating income margin 12.7 % 8.9 % Equity in net income from affiliated companies (27.7) (27.7) — — % Interest expense, net 37.2 37.0 0.2 0.5 % Debt extinguishment costs — 26.9 (26.9) (100.0) % Other expense, net 0.2 4.5 (4.3) (95.6) % Income from continuing operations before income taxes and noncontrolling interest 94.7 13.9 80.8 581.3 % Provision for income taxes 24.9 12.1 12.8 105.8 % Effective tax rate 26.3 % 87.1 % Net income from continuing operations 69.8 1.8 68.0 NM Net income (loss) from discontinued operations, net of tax 3.9 (141.4) 145.3 (102.8) % Net income (loss) 73.7 (139.6) 213.3 (152.8) % Less: Net income attributable to the noncontrolling interest - discontinued operations — 0.3 (0.3) (100.0) % Net income (loss) attributable to Ecovyst Inc. $ 73.7 $ (139.9) $ 213.6 (152.7) % Sales Years ended December 31, Change 2022 2021 $ % (in millions, except percentages) Sales: Ecoservices $ 702.5 $ 500.5 $ 202.0 40.4 % Catalyst Technologies 117.7 110.7 7.0 6.3 % Total sales $ 820.2 $ 611.2 $ 209.0 34.2 % Ecoservices : Sales in Ecoservices for the year ended December 31, 2022 were $702.5 million, an increase of $202.0 million, or 40.4%, compared to sales of $500.5 million for the year ended December 31, 2021.
Years ended December 31, Change 2023 2022 $ % (in millions, except percentages) Sales $ 691.1 $ 820.2 $ (129.1) (15.7) % Cost of goods sold 493.2 595.5 (102.3) (17.2) % Gross profit 197.9 224.7 (26.8) (11.9) % Gross profit margin 28.6 % 27.4 % Selling, general and administrative expenses 79.2 85.3 (6.1) (7.2) % Other operating expense, net 22.0 35.0 (13.0) (37.1) % Operating income 96.7 104.4 (7.7) (7.4) % Operating income margin 14.0 % 12.7 % Equity in net income from affiliated companies (30.6) (27.7) (2.9) 10.5 % Interest expense, net 44.7 37.2 7.5 20.2 % Other expense, net 0.6 0.2 0.4 200.0 % Income from continuing operations before income taxes 82.0 94.7 (12.7) (13.4) % Provision for income taxes 10.8 24.9 (14.1) (56.6) % Effective tax rate 13.2 % 26.3 % Net income from continuing operations 71.2 69.8 1.4 2.0 % Net income from discontinued operations, net of tax — 3.9 (3.9) (100.0) % Net income $ 71.2 $ 73.7 $ (2.5) (3.4) % Sales Years ended December 31, Change 2023 2022 $ % (in millions, except percentages) Sales: Ecoservices $ 584.8 $ 702.5 $ (117.7) (16.8) % Advanced Materials & Catalysts 106.3 117.7 (11.4) (9.7) % Total sales $ 691.1 $ 820.2 $ (129.1) (15.7) % Ecoservices : Sales in Ecoservices for the year ended December 31, 2023 were $584.8 million, a decrease of $117.7 million, or 16.8%, compared with sales of $702.5 million for the year ended December 31, 2022.
As of December 31, 2022, we had cash and cash equivalents of $110.9 million and availability of $59.7 million under our ABL Facility, after giving effect to $4.0 million of outstanding letters of credit and no revolving credit facility borrowings, for a total available liquidity of $170.6 million. Our ABL Facility has one financial covenant to maintain.
We may, from time to time, increase borrowings under our ABL Facility to meet our future cash needs. As of December 31, 2023, we had cash and cash equivalents of $88.4 million and availability of $63.8 million under our ABL Facility, after giving effect to $4.0 million of outstanding letters of credit, for a total available liquidity of $152.2 million.
We consider stand-ready provisions and reservation of capacity fees to be performance obligations satisfied over time. Revenues related to stand-ready provisions and reservation of capacity fees are recognized on a ratable basis throughout the contract term and billed to the customer on a monthly basis.
Revenues related to stand-ready provisions and reservation of capacity fees are recognized on a ratable basis throughout the contract term and billed to the customer on a monthly basis. As described above, our MSAs with our customers may outline prices for individual products or contract provisions.
We identify a performance obligation in a contract for each promised good that is separately identifiable from other promises in the contract and for which the customer can benefit from the good. The majority of our contracts have a single performance obligation, which is the promise to transfer individual goods to the customer.
Absent either a MSA or pricing quote, we consider an individual purchase order to create enforceable rights and obligations. 58 We identify a performance obligation in a contract for each promised good that is separately identifiable from other promises in the contract and for which the customer can benefit from the good.
(g) Includes the impact of restructuring, integration and business optimization expenses which are incremental costs that are not representative of our ongoing business operations. 51 (h) Other costs consist of adjustments for defined benefit pension plan (benefit) costs and certain expenses that are not core to our ongoing business operations, including environmental remediation-related costs, capital and franchise taxes.
(h) Other consists of adjustments for items that are not core to our ongoing business operations. These adjustments include environmental remediation and other legal costs, expenses for capital and franchise taxes, and defined benefit pension and postretirement plan (benefits) costs, for which our obligations are under plans that are frozen.
The increase was due to higher earnings of $6.4 million generated by the Zeolyst Joint Venture during the year ended December 31, 2021 as compared to the year ended December 31, 2020. 53 The following is our consolidated statement of income and a summary of financial results for the years ended December 31, 2021 and 2020.
The increase was primarily due to higher sales within the Zeolyst Joint Venture partially offset by the impact of unfavorable fixed cost absorption. 46 The following is our consolidated statement of income and a summary of financial results for the years ended December 31, 2023 and 2022.
Pension Funding We paid an immaterial amount in cash contributions into our defined benefit pension plans and other postretirement plans in December 31, 2022 and 2021, respectively and $3.3 million in 2020. The net periodic pension and postretirement expense was $1.0 million, $0.3 million, and $0.4 million for those same periods, respectively.
The net periodic pension and postretirement expense (benefit) was $0.1 million, $(1.0) million, and $(0.3) million for those same periods, respectively. As of December 31, 2023 and 2022, our pension plans and other post-retirement benefit plans were underfunded by $5.4 million and $6.7 million, respectively.